Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations

Triacontanol (TA, C30H62O), abundantly present in plant cuticle waxes and bee waxes, has been found to display promising anti-neoplastic potentials. As a long chain fatty alcohol, TA possesses limited aqueous solubility, which hinders its medicinal application. To overcome its solubility barrier, a...

Full description

Bibliographic Details
Main Authors: Yimeng Zhou, Ning Li, Zhixia Qiu, Xiaoyu Lu, Min Fang, Xijing Chen, Lili Ren, Guangji Wang, Pingkai Ouyang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2018.1477864
_version_ 1831774242681651200
author Yimeng Zhou
Ning Li
Zhixia Qiu
Xiaoyu Lu
Min Fang
Xijing Chen
Lili Ren
Guangji Wang
Pingkai Ouyang
author_facet Yimeng Zhou
Ning Li
Zhixia Qiu
Xiaoyu Lu
Min Fang
Xijing Chen
Lili Ren
Guangji Wang
Pingkai Ouyang
author_sort Yimeng Zhou
collection DOAJ
description Triacontanol (TA, C30H62O), abundantly present in plant cuticle waxes and bee waxes, has been found to display promising anti-neoplastic potentials. As a long chain fatty alcohol, TA possesses limited aqueous solubility, which hinders its medicinal application. To overcome its solubility barrier, a polymer prodrug was synthesized through attaching TA to poly ethylene glycol (PEG), using succinic acid as a linker with bifunctional amide and ester bonds. Anti-neoplastic effects of PEG-TA were assessed in LoVo and MCF7 cells, anti-proliferative and apoptosis-inducing activities were subsequently confirmed in mouse xenograft model. Encouragingly, PEG-TA possessed selective anti-cancer ability. It did not exhibit significant cytotoxicity on normal cells. Mechanistic examination revealed inhibition of NF-κB nuclear translocation, suppression on matrix degradation enzyme and down-regulation of angiogenic signaling might contribute to its anti-malignant effects. Pharmacokinetics clearly indicated PEGylated TA (named as mPEG2K-SA-TA) substantially enhanced TA delivery with increased plasma exposure (19,791 vs. 336.25 ng·mL−1·h−1, p < .001), mean residence time (8.46 vs. 2.95 h, p < .001) and elimination half-life (7.78 vs. 2.57 h, p < .001) compared to those of original TA. Moreover, mPEG2K-SA-TA appeared to be safe in preliminary toxicological assessment. PEGylated TA also emerged as a functional carrier to deliver hydrophobic chemotherapeutic agents, since it readily self-assembled to micelles in aqueous solution with a low critical micelle concentration (CMC, 19.1 µg·mL−1). Conclusively, PEG-TA conjugate displayed superior anti-neoplastic activities and low toxicity, as well as facilitated the delivery of other hydrophobic agents, which appeared to be an innovative strategy for cancer therapy.
first_indexed 2024-12-22T08:50:43Z
format Article
id doaj.art-d0cb1642dc6d4db0b8cdccd6117ef9d0
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-22T08:50:43Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-d0cb1642dc6d4db0b8cdccd6117ef9d02022-12-21T18:31:58ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642018-01-012511546155910.1080/10717544.2018.14778641477864Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluationsYimeng Zhou0Ning Li1Zhixia Qiu2Xiaoyu Lu3Min Fang4Xijing Chen5Lili Ren6Guangji Wang7Pingkai Ouyang8China Pharmaceutical UniversityChina Pharmaceutical UniversityChina Pharmaceutical UniversityChina Pharmaceutical UniversityChina Pharmaceutical UniversityChina Pharmaceutical UniversityNanjing Tech UniversityChina Pharmaceutical UniversityNanjing Tech UniversityTriacontanol (TA, C30H62O), abundantly present in plant cuticle waxes and bee waxes, has been found to display promising anti-neoplastic potentials. As a long chain fatty alcohol, TA possesses limited aqueous solubility, which hinders its medicinal application. To overcome its solubility barrier, a polymer prodrug was synthesized through attaching TA to poly ethylene glycol (PEG), using succinic acid as a linker with bifunctional amide and ester bonds. Anti-neoplastic effects of PEG-TA were assessed in LoVo and MCF7 cells, anti-proliferative and apoptosis-inducing activities were subsequently confirmed in mouse xenograft model. Encouragingly, PEG-TA possessed selective anti-cancer ability. It did not exhibit significant cytotoxicity on normal cells. Mechanistic examination revealed inhibition of NF-κB nuclear translocation, suppression on matrix degradation enzyme and down-regulation of angiogenic signaling might contribute to its anti-malignant effects. Pharmacokinetics clearly indicated PEGylated TA (named as mPEG2K-SA-TA) substantially enhanced TA delivery with increased plasma exposure (19,791 vs. 336.25 ng·mL−1·h−1, p < .001), mean residence time (8.46 vs. 2.95 h, p < .001) and elimination half-life (7.78 vs. 2.57 h, p < .001) compared to those of original TA. Moreover, mPEG2K-SA-TA appeared to be safe in preliminary toxicological assessment. PEGylated TA also emerged as a functional carrier to deliver hydrophobic chemotherapeutic agents, since it readily self-assembled to micelles in aqueous solution with a low critical micelle concentration (CMC, 19.1 µg·mL−1). Conclusively, PEG-TA conjugate displayed superior anti-neoplastic activities and low toxicity, as well as facilitated the delivery of other hydrophobic agents, which appeared to be an innovative strategy for cancer therapy.http://dx.doi.org/10.1080/10717544.2018.1477864pegylated triacontanoltriacontanolmicelledrug deliveryanti-neoplastic
spellingShingle Yimeng Zhou
Ning Li
Zhixia Qiu
Xiaoyu Lu
Min Fang
Xijing Chen
Lili Ren
Guangji Wang
Pingkai Ouyang
Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
Drug Delivery
pegylated triacontanol
triacontanol
micelle
drug delivery
anti-neoplastic
title Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
title_full Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
title_fullStr Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
title_full_unstemmed Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
title_short Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations
title_sort superior anti neoplastic activities of triacontanol peg conjugate synthesis characterization and biological evaluations
topic pegylated triacontanol
triacontanol
micelle
drug delivery
anti-neoplastic
url http://dx.doi.org/10.1080/10717544.2018.1477864
work_keys_str_mv AT yimengzhou superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT ningli superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT zhixiaqiu superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT xiaoyulu superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT minfang superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT xijingchen superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT liliren superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT guangjiwang superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations
AT pingkaiouyang superiorantineoplasticactivitiesoftriacontanolpegconjugatesynthesischaracterizationandbiologicalevaluations